AACE	American Association of Clinical Endocrinology
AASLD	American Association for the Study of Liver Diseases
ACC	Acetyl-CoA Carboxylase
ALEH	Latin American Association for the Study of the Liver
ALP	Alkaline Phosphate
ALT	Alanine Aminotransferase
AMPK	Adenosine 5’-Monophosphate
(AMP)	Activated Protein Kinase
AST	Aspartate Aminotransferase
BLBLIs	β-Lactam/β-Lactamase Inhibitor Combinations
BMI	Body-Mass Index
CAP	Controlled Attenuation Parameter
CK-18	Cytokeratin-18
CKD	Chronic Kidney Disease
CRF	Cardiorespiratory Fitness
CT	Computed Tomography
DGATs	Diacylglycerol Acyltransferases
DMT2	Type 2 Diabetes Mellitus
DPP4i	Dipeptidyl Peptidase-4 inhibitor
EASD	European Association for the Study of Diabetes
EASL	European Association for the Study of the Liver
EASO	European Association for the Study of Obesity
FASN	Fatty-Acid Synthase
FGF-21	Fibroblast Growth Factor 21
FIB-4	Fibrosis-4 Index
FLI	Fatty Liver Index
FNI	Fibrotic Nonalcoholic steatohepatitis Index
FXR	Farnesoid X Receptor
GCG	Glucagon
GCGR	Glucagon Receptor
GGT	Gamma-Glutamyl Transferase
GH	Growth Hormone
GIP	Glucose-Dependent Insulinotropic Peptide
GLP-1	Glucagon-like Peptide-1
GLP-1RA	GLP-1 Receptor Agonists
HCC	Hepatocellular Carcinoma
HDL	High-Density Lipoprotein
HF	Heart Failure
HIS	Intrahepatic Steatosis
HOMA-IR	Homeostasis Model Assessment of Insulin Resistance
IGF-1	Insulin-like Growth Factor-1
IHL	Intrahepatic Lipid
IL	Interleukin
KHKis	Ketohexokinase inhibitors
LAI	Liver Attenuation Index
LFC	Liver Fat Content
LFTs	Liver Function Tests
LPS	Lipopolysaccharides
LSM	Liver Stiffness Measurement
MAFLD	Metabolic-Associated Fatty Liver Disease
MASH	Metabolic Dysfunction-Associated Steatohepatitis
MASLD	Metabolic Dysfunction-Associated Steatotic Liver Disease
Met-ALD	Metabolic Alcohol-Related Liver Disease
MRI	Magnetic Resonance Imaging
MRI-PDFF	MRI-Proton Density Fat Fraction
mTOR	mammalian Target of Rapamycin
NAFIC score	NASH, Ferritin, Insulin, and type IV Collagen 7S score
NAFLD	Nonalcoholic Fatty Liver Disease
NAS	NAFLD Activity Score
NASH	Nonalcoholic Steatohepatitis
NFS	NAFLD Fibrosis Score
PCSK9i	inhibitor of Proprotein Convertase Subtilisin/Kexin 9
PI13-AKT	Phosphatidylinositol 3 Kinase-protein Kinase B
PPAR 9 (α) alpha	Peroxisome Proliferator-Activated Receptors alpha
PPARγ	Peroxisome Proliferator-Activated Receptors gamma
Pro-C3	N-terminal type III collagen propeptide
PUFA	Polyunsaturated Fatty Acid
RCT	Randomized Controlled Trial
SGLT-2	Sodium-Glucose Cotransporter-2
SGLT-2is	Sodium-Glucose Cotransporter-2 inhibitors
SHBG	Sex-Hormone Binding Protein
SLD	Steatotic Liver Disease
SPPARM	Selective Peroxisome Proliferator-Activated Receptor Modulators
SUCRA	Surface Under the Cumulative Ranking Curve
SWV	Shear-Wave Velocity
TG	Triglyceride
TGF	Transforming Growth Factor
TLC	Therapeutic Lifestyle Change
TNF-alfa (α)	Tumor Necrosing Factor alpha
TRb	Thyroid Receptor beta
UDCA	Ursodeoxycholic Acid